WWW.NATURE.COM
Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease
Nature, Published online: 16 April 2025; doi:10.1038/s41586-025-08700-0After transplantation into the brain of patients with Parkinson’s disease, allogeneic dopaminergic progenitors derived from induced pluripotent stem cells survived, produced dopamine and did not form tumours, therefore suggesting safety and potential clinical benefits for Parkinson’s disease.
0 Commentarios 0 Acciones 31 Views